Quote:
Originally Posted by spiderplant
Deals done:
AstraZeneca (400 million doses) -- fridge
Sanofi-GSK (300 million doses) -- presumably fridge, as it's based on a flu vaccine
Johnson and Johnson (400 million doses) -- fridge
BioNTech-Pfizer (600 million doses) -- supercooled
CureVac (405 million doses) -- fridge (mRNA, incidentally)
Moderna (160 million doses) -- 30 days fridge, 6 months freezer
Negotiating:
Novavax (200 million doses) -- fridge
Valneva (60 million doses) -- fridge
|
Very few of which are anywhere near delivering significant numbers of doses to the EU. The Pfizer vaccine is by far the biggest deal the EU has done as well as being the earliest to be ready. Within the EU, right now, if you’re lucky enough to get a vaccine in the next 2 months it is unlikely to be anything other than that one.
Incidentally the Sanofi-GSK vaccine failed to produce an immune response in over 50s and reformulation work means it won’t now produce a working product before the end of the year. For the time being Sanofi’s manufacturing capacity has been turned over to making yet more of the Pfizer-BioNTech product.